TherapeuticsMD, Inc. (TXMD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1161641,
    "name": "TherapeuticsMD, Inc.",
    "stock_name": "TherapeuticsMD, Inc.",
    "full_name": "TherapeuticsMD, Inc.",
    "name_url": "stocks-analysis/therapeuticsmd-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.61",
    "chg": 0.15,
    "chgp": "10.27%",
    "dir": 1,
    "prev_price": "1.46",
    "mcapval": "12.50",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US88338N2062",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "41.59 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/therapeuticsmd-inc-1161641-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "TherapeuticsMD Stock Forms Golden Cross, Signaling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/therapeuticsmd-stock-forms-golden-cross-signaling-potential-bullish-breakout-3673959",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TherapeuticsMDI_goldencross_3673959.png",
        "date": "2025-11-05 15:04:07",
        "description": "TherapeuticsMD, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a year-over-year decline of 24.47%, the company has rebounded with a 36.05% increase year-to-date. Current performance metrics show mixed signals, prompting investor interest in future trading activity."
      },
      {
        "title": "TherapeuticsMD Forms Death Cross, Signaling Potential Bearish Trend Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/therapeuticsmd-forms-death-cross-signaling-potential-bearish-trend-ahead-3571390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/TherapeuticsMDI_dealthcross_3571390.png",
        "date": "2025-09-25 16:57:05",
        "description": "TherapeuticsMD, Inc. has recently encountered a technical event known as a Death Cross, indicating potential bearish trends. While the stock has shown short-term resilience, its longer-term performance raises concerns, with a significant decline over the past year compared to broader market gains, suggesting caution for investors."
      },
      {
        "title": "Is TherapeuticsMD, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-therapeuticsmd-inc-technically-bullish-or-bearish-3547320",
        "imagepath": "",
        "date": "2025-09-20 19:52:41",
        "description": "As of 8 September 2025, the technical trend for TherapeuticsMD, Inc. has changed from sideways to mildly bullish. The weekly MACD is bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, supporting the overall positive trend. However, the Bollinger Bands and KST on a weekly basis are bearish, and the OBV is mildly bearish on a monthly basis, suggesting some caution. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -2.70% and -5.26% compared to the S&P 500's 1.05% and 2.33%, respectively. However, year-to-date, the stock has outperformed the index with a return of 25.58% versus 12.22%. Overall, the current stance is mildly bullish, but the mixed indicators suggest a need for careful monitoring...."
      },
      {
        "title": "Is TherapeuticsMD, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-therapeuticsmd-inc-overvalued-or-undervalued-3543718",
        "imagepath": "",
        "date": "2025-09-20 18:26:47",
        "description": "As of 12 November 2024, the valuation grade for TherapeuticsMD, Inc. has moved from does not qualify to risky, indicating a deterioration in its investment appeal. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 0.54 and an EV to Sales ratio of 5.29, which suggests that the market is pricing the company at a premium despite its poor performance. Additionally, the EV to EBITDA ratio stands at -3.66, reflecting significant operational challenges.\n\nWhen compared to peers, TherapeuticsMD has a P/E ratio of -12.50, while Checkpoint Therapeutics, Inc. has a P/E of -6.58 and Journey Medical Corp. has a P/E of -18.70, highlighting that TherapeuticsMD is underperforming relative to its industry. The company's recent stock performance has been troubling, with a 1-year return of -34.94% compared to the S&P 500's 17.14%, reinforcing the notion that it is curr..."
      }
    ],
    "total": 9,
    "sid": "1161641",
    "stock_news_url": "https://www.marketsmojo.com/news/therapeuticsmd-inc-1161641"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

TherapeuticsMD Stock Forms Golden Cross, Signaling Potential Bullish Breakout

2025-11-05 15:04:07

TherapeuticsMD, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a year-over-year decline of 24.47%, the company has rebounded with a 36.05% increase year-to-date. Current performance metrics show mixed signals, prompting investor interest in future trading activity.

TherapeuticsMD Forms Death Cross, Signaling Potential Bearish Trend Ahead

2025-09-25 16:57:05

TherapeuticsMD, Inc. has recently encountered a technical event known as a Death Cross, indicating potential bearish trends. While the stock has shown short-term resilience, its longer-term performance raises concerns, with a significant decline over the past year compared to broader market gains, suggesting caution for investors.

Is TherapeuticsMD, Inc. technically bullish or bearish?

2025-09-20 19:52:41

As of 8 September 2025, the technical trend for TherapeuticsMD, Inc. has changed from sideways to mildly bullish. The weekly MACD is bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, supporting the overall positive trend. However, the Bollinger Bands and KST on a weekly basis are bearish, and the OBV is mildly bearish on a monthly basis, suggesting some caution. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -2.70% and -5.26% compared to the S&P 500's 1.05% and 2.33%, respectively. However, year-to-date, the stock has outperformed the index with a return of 25.58% versus 12.22%. Overall, the current stance is mildly bullish, but the mixed indicators suggest a need for careful monitoring....

Is TherapeuticsMD, Inc. overvalued or undervalued?

2025-09-20 18:26:47

As of 12 November 2024, the valuation grade for TherapeuticsMD, Inc. has moved from does not qualify to risky, indicating a deterioration in its investment appeal. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 0.54 and an EV to Sales ratio of 5.29, which suggests that the market is pricing the company at a premium despite its poor performance. Additionally, the EV to EBITDA ratio stands at -3.66, reflecting significant operational challenges. When compared to peers, TherapeuticsMD has a P/E ratio of -12.50, while Checkpoint Therapeutics, Inc. has a P/E of -6.58 and Journey Medical Corp. has a P/E of -18.70, highlighting that TherapeuticsMD is underperforming relative to its industry. The company's recent stock performance has been troubling, with a 1-year return of -34.94% compared to the S&P 500's 17.14%, reinforcing the notion that it is curr...

View All News